← Leaderboards
Rudolf Jaenisch
Whitehead Institute For Biomedical Res
$45,589,957
Attributed
$60,888,479
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$60,888,479 · 11
By mechanism
R01$42,157,686 · 7
R37$16,770,823 · 2
R35$980,565 · 1
RC1$979,405 · 1
Top collaborators
- Richard A Young10 shared
- Kevin Esvelt6 shared
- Wayne A. Marasco6 shared
- Styliani Markoulaki6 shared
- Sam R. Telford6 shared
- Bradley T Hyman5 shared
- Manolis Kellis5 shared
- Richard H Myers5 shared
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesEmbryonic Stem CellCellsIn VitroGene TargetingNeuronsMediatingMolecularEpigenetic ProcessMutationCell LineInduced Pluripotent Stem CellBaseAllelesPhenotypeGene ExpressionGenerationsIn VivoNuclear TransferSiteOncogenesStem CellsComplexTechnology
Grant awards (70)
Heritable immunization of the white-footed mouse reservoir of Lyme disease$825,096
R01 · FY2025 · AI
Heritable immunization of the white-footed mouse reservoir of Lyme disease$854,479
R01 · FY2024 · AI
Transcriptional condensates, epigenetic editing and Rett Syndrome$881,324
R01 · FY2023 · MH · contact PI
Heritable immunization of the white-footed mouse reservoir of Lyme disease$881,046
R01 · FY2023 · AI
Heritable immunization of the white-footed mouse reservoir of Lyme disease$904,332
R01 · FY2022 · AI
Transcriptional condensates, epigenetic editing and Rett Syndrome$892,575
R01 · FY2022 · MH · contact PI
Heritable immunization of the white-footed mouse reservoir of Lyme disease$235,144
R01 · FY2022 · AI
Epigenomic, transcriptional and cellular dissection of Alzheimer's variants$1,552,886
R01 · FY2021 · AG
Heritable immunization of the white-footed mouse reservoir of Lyme disease$957,529
R01 · FY2021 · AI
Transcriptional condensates, epigenetic editing and Rett Syndrome$903,497
R01 · FY2021 · MH · contact PI
Epigenomic, transcriptional and cellular dissection of Alzheimer's variants$1,578,214
R01 · FY2020 · AG
Transcriptional condensates, epigenetic editing and Rett Syndrome$962,212
R01 · FY2020 · MH · contact PI
Epigenomic, transcriptional and cellular dissection of Alzheimer's variants$1,610,182
R01 · FY2019 · AG
Transcriptional condensates, epigenetic editing and Rett Syndrome$973,050
R01 · FY2019 · MH · contact PI
Epigenomic, transcriptional and cellular dissection of Alzheimer's variants$1,642,247
R01 · FY2018 · AG
An iPSC based platform for functionally assessing genetic and environmental risk$989,717
R01 · FY2018 · NS · contact PI
Genetically engineered human pluripotent stem cells as a platform to define the b$555,120
R01 · FY2018 · MH · contact PI
Epigenomic, transcriptional and cellular dissection of Alzheimer's variants$1,527,396
R01 · FY2017 · AG
An iPSC based platform for functionally assessing genetic and environmental risk$989,717
R01 · FY2017 · NS · contact PI
In Vitro Reprogramming of Somatic Cells into Pluripotent ES-like Cells$845,056
R37 · FY2017 · HD · contact PI
Genetically engineered human pluripotent stem cells as a platform to define the b$555,120
R01 · FY2017 · MH · contact PI
An iPSC based platform for functionally assessing genetic and environmental risk$989,717
R01 · FY2016 · NS · contact PI
In Vitro Reprogramming of Somatic Cells into Pluripotent ES-like Cells$836,607
R37 · FY2016 · HD · contact PI
Genetically engineered human pluripotent stem cells as a platform to define the b$545,374
R01 · FY2016 · MH · contact PI
An iPSC based platform for functionally assessing genetic and environmental risk$1,003,223
R01 · FY2015 · NS · contact PI
In Vitro Reprogramming of Somatic Cells into Pluripotent ES-like Cells$823,928
R37 · FY2015 · HD · contact PI
Genetically engineered human pluripotent stem cells as a platform to define the b$545,374
R01 · FY2015 · MH · contact PI
An iPSC based platform for functionally assessing genetic and environmental risk$1,026,973
R01 · FY2014 · NS · contact PI
In Vitro Reprogramming of Somatic Cells into Pluripotent ES-like Cells$821,395
R37 · FY2014 · HD · contact PI
Genetically engineered human pluripotent stem cells as a platform to define the b$605,970
R01 · FY2014 · MH · contact PI
In Vitro Reprogramming of Somatic Cells into Pluripotent ES-like Cells$845,056
R37 · FY2013 · HD · contact PI
Programming and Reprogramming Human Cells$793,796
R01 · FY2013 · CA · contact PI
Programming and Reprogramming Human Cells$849,689
R01 · FY2012 · CA · contact PI
In Vitro Reprogramming of Somatic Cells into Pluripotent ES-like Cells$768,246
R37 · FY2012 · HD · contact PI
Programming and Reprogramming Human Cells$852,794
R01 · FY2011 · CA · contact PI
In Vitro Reprogramming of Somatic Cells into Pluripotent ES-like Cells$764,654
R37 · FY2011 · HD · contact PI
Patient-specific iPS cells to study myeloproliferative disease.$979,405
RC1 · FY2010 · CA · contact PI
Epigenetics, Stem Cells, and Cancer$900,709
R01 · FY2010 · CA · contact PI
Programming and Reprogramming Human Cells$886,413
R01 · FY2010 · CA · contact PI
In Vitro Reprogramming of Somatic Cells into Pluripotent ES-like Cells$772,378
R37 · FY2010 · HD · contact PI
In Vitro Reprogramming of Somatic Cells into Pluripotent ES-like Cells$311,563
R37 · FY2010 · HD · contact PI
Epigenetics, Stem Cells, and Cancer$886,353
R01 · FY2009 · CA · contact PI
Programming and Reprogramming Human Cells$868,894
R01 · FY2009 · CA · contact PI
In Vitro Reprogramming of Somatic Cells into Pluripotent ES-like Cells$757,458
R37 · FY2009 · HD · contact PI
GENOMIC IMPRINTING AND THE CLONING OF MICE$1,226,340
R37 · FY2008 · CA · contact PI
Epigenetics, Stem Cells, and Cancer$863,846
R01 · FY2008 · CA · contact PI
In Vitro Reprogramming of Somatic Cells into Pluripotent ES-like Cells$735,392
R01 · FY2008 · HD · contact PI
GENOMIC IMPRINTING AND THE CLONING OF MICE$1,217,398
R37 · FY2007 · CA · contact PI
Epigenetics, Stem Cells, and Cancer$858,663
R01 · FY2007 · CA · contact PI
Nuclear Cloning and the Reprogramming of the Genome$810,092
R01 · FY2007 · HD · contact PI
GENOMIC IMPRINTING AND THE CLONING OF MICE$1,218,625
R37 · FY2006 · CA · contact PI
Epigenetics, Stem Cells, and Cancer$859,815
R01 · FY2006 · CA · contact PI
Nuclear Cloning and the Reprogramming of the Genome$814,026
R01 · FY2006 · HD · contact PI
GENOMIC IMPRINTING AND THE CLONING OF MICE$1,211,603
R37 · FY2005 · CA
DNA METHYLATION, GENE REGULATION, AND CANCER$854,867
R01 · FY2005 · CA
Nuclear Cloning and the Reprogramming of the Genome$812,964
R01 · FY2005 · HD
GENOMIC IMPRINTING AND THE CLONING OF MICE$1,054,154
R37 · FY2004 · CA
DNA METHYLATION, GENE REGULATION, AND CANCER$899,401
R01 · FY2004 · CA
Nuclear Cloning and the Reprogramming of the Genome$792,086
R01 · FY2004 · HD
GENOMIC IMPRINTING AND THE CLONING OF MICE$967,339
R37 · FY2003 · CA
DNA METHYLATION, GENE REGULATION, AND CANCER$786,657
R01 · FY2003 · CA
Nuclear Cloning and the Reprogramming of the Genome$769,754
R01 · FY2003 · HD
GENOMIC IMPRINTING AND THE CLONING OF MICE$763,615
R37 · FY2002 · CA
DNA METHYLATION, GENE REGULATION, AND CANCER$645,180
R01 · FY2002 · CA
GENOMIC IMPRINTING AND THE CLONING OF MICE$743,479
R37 · FY2001 · CA
DNA METHYLATION, GENE REGULATION, AND CANCER$628,781
R01 · FY2001 · CA
GENETIC DISEASE, CANCER, AND MAMMALIAN DEVELOPMENT$854,541
R35 · FY2000 · CA
GENOMIC IMPRINTING AND THE CLONING OF MICE$821,929
R37 · FY2000 · CA
GENETIC DISEASE, CANCER, AND MAMMALIAN DEVELOPMENT$64,656
R35 · FY2000 · CA
GENETIC DISEASE, CANCER, AND MAMMALIAN DEVELOPMENT$61,368
R35 · FY2000 · CA